Assembly Bio Showcases Positive Phase 1B Data For ABI-5366
09 Apr 2026 //
GLOBENEWSWIRE
Gilead Turns Down Assembly`s Ph. 1-Stage HBV Antiviral
21 Mar 2026 //
FIERCE BIOTECH
Gilead Turns Down Assembly`s Ph. 1-Stage HBV Antiviral
20 Mar 2026 //
FIERCE BIOTECH
Gilead Licenses Assembly Bio`s Herpes Drugs After Positive Phase
24 Dec 2025 //
INDPHARMAPOST
Gilead pays $35M to license pair of HSV assets from Assembly Bio
24 Dec 2025 //
BUSINESSWIRE
Assembly Antivirals Cut Lesions, Shedding by 90%
09 Dec 2025 //
BIOSPACE
Assembly Biosciences Reports Positive ABI-1179, ABI-5366 Data
08 Dec 2025 //
GLOBENEWSWIRE
Assembly Bio Reveals Q3 2025 Financials & Recent Developments
10 Nov 2025 //
GLOBENEWSWIRE
Assembly Bio Reveals Promising ABI-4334 Phase 1B Data at AASLD
07 Nov 2025 //
GLOBENEWSWIRE
Assembly Bio Announces To Attend Investor Conference
14 Oct 2025 //
GLOBENEWSWIRE
Assembly Bio Unveils ABI-5366 Phase 1B Data For HSV Inhibitor
10 Oct 2025 //
GLOBENEWSWIRE
Positive Interim Results for ABI-5366 in Phase 1b Study on Herpes
08 Aug 2025 //
GLOBENEWSWIRE
Assembly Biosciences Prices $175 Million Equity Financings
08 Aug 2025 //
GLOBENEWSWIRE
Assembly Biosciences Unveils Q2 2025 Financials Result
06 Aug 2025 //
GLOBENEWSWIRE
Assembly Biosciences Unveils Phase 1a Data for ABI-6250
06 Aug 2025 //
GLOBENEWSWIRE
Assembly Bio Shares Genital Herpes Data at STI 2025
26 Jul 2025 //
GLOBENEWSWIRE
Assembly Biosciences Doses First Participant in Phase 1b Trial
30 Jun 2025 //
GLOBENEWSWIRE
Assembly Reports Positive Ph1b Data for ABI-4334 in Hepatitis B
25 Jun 2025 //
GLOBENEWSWIRE
Assembly Biosciences at Jefferies 2025 Global Healthcare Conf.
27 May 2025 //
GLOBENEWSWIRE
Assembly Bio Presents New Hepatitis B/D Data at EASL Congress
07 May 2025 //
GLOBENEWSWIRE
Assembly Biosciences Presents New Data on Long-Acting Herpes Cand
09 Apr 2025 //
GLOBENEWSWIRE
Assembly Biosciences Reports 2024 Financial Results & Highlights
20 Mar 2025 //
GLOBENEWSWIRE
Assembly Biosciences Doses First Participant In Ph 1a ABI-6250 Study
26 Feb 2025 //
GLOBENEWSWIRE
Assembly Reports Positive Ph 1a Data For ABI-1179 In Genital Herpes
20 Feb 2025 //
GLOBENEWSWIRE
Assembly Bio Reports Phase 1b Results for ABI-4334 in Hepatitis B
26 Dec 2024 //
GLOBENEWSWIRE
Assembly Bio Reports Q3 2024 Financial Results & Recent Updates
07 Nov 2024 //
GLOBENEWSWIRE
Assembly Bio Reports Positive Phase 1a ABI-5366 Results
23 Sep 2024 //
GLOBENEWSWIRE
Assembly Biosciences Reports Q2 2024 Results And Recent Updates
08 Aug 2024 //
GLOBENEWSWIRE
Atea: Positive Initial Phase 2 Bemnifosbuvir+Ruzasvir Data In HCV At EASL
05 Jun 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support